P
Paulus Kirchhof
Researcher at University of Birmingham
Publications - 659
Citations - 119822
Paulus Kirchhof is an academic researcher from University of Birmingham. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 100, co-authored 558 publications receiving 106459 citations. Previous affiliations of Paulus Kirchhof include United States Department of Veterans Affairs & Georgetown University Medical Center.
Papers
More filters
Journal ArticleDOI
Generation and characterization of SCN5A loss-of-function mutant mice modeling human brugada syndrome
Patrick Schweizer,T. Fink,P. Yampolsky,Claudia Seyler,Larissa Fabritz,Paulus Kirchhof,Rüdiger Becker,Michael Koenen,Hugo A. Katus,Dierk Thomas +9 more
Journal ArticleDOI
The established and the challenger: A direct comparison of current cryoballoon technologies for pulmonary vein isolation.
Fabian Moser,Laura Rottner,Julia Moser,Ruben Schleberger,Marc D Lemoine,Paula Münkler,Leon Dinshaw,Paulus Kirchhof,Paulus Kirchhof,Bruno Reissmann,Feifan Ouyang,Andreas Rillig,Andreas Metzner +12 more
TL;DR: In this paper, the authors compared the safety, efficacy and biophysical characteristics of a novel cryoablation system (POLARx™; Boston Scientific) to a commonly used and clinically well characterized system (Arctic Front Advance Pro™, AFA; Medtronic).
Journal ArticleDOI
Oral anticoagulation after catheter ablation of atrial fibrillation: caught in the attribution trap?
TL;DR: The indication for long-term anticoagulation should be based on clinical stroke risk factors thereafter, and Karasoy and colleagues have now reported on a cohort of 4050 patients who underwent a first catheter ablation for AF in Denmark from 2000 to 2011.
Journal ArticleDOI
Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set
Emre Oto,Sercan Okutucu,Deniz Katircioglu-Öztürk,Halil Altay Güvenir,Ergun Karaagaoglu,Martin Borggrefe,Günter Breithardt,Andreas Goette,Ursula Ravens,Gerhard Steinbeck,Karl Wegscheider,Ali Oto,Paulus Kirchhof +12 more
TL;DR: Data mining with supportive statistical analyses identified variables of the Flecainide Short-Long (Flec-SL-AFNET 3) trial dataset that are associated with the primary outcome of the trial, recurrence of persistent atrial fibrillation (AF) or death.
Journal ArticleDOI
Electrocardiographic markers of sudden cardiac death
TL;DR: The past decade has identified another potentially large population of patients at risk for SCD due to primary electrical diseases, who often suffer from monogenic genetic abnormalities and can often be identified by a careful analysis of the surface electrocardiogram (ECG).